Optical microangiography: A label-free 3-D imaging technology to visualize and quantify blood circulations within tissue beds in vivo

IEEE Journal on Selected Topics in Quantum Electronics

Volumn 16, Issue 3, 2010, Pages 545-554

  Wang, Ruikang K ^a  

^a Oregon Health and Science University Department of Biomedical Engineering   (United States)

Author keywords

Cerebral blood flow (CBF); Fourier domain optical coherence tomography (FDOCT); Microcirculation; Neurological disease models; Optical microangiography (OMAG); Retinal blood flow

Indexed keywords

CEREBRAL BLOOD FLOW; FOURIER DOMAIN OPTICAL COHERENCE TOMOGRAPHY (FDOCT); FOURIER-DOMAIN OPTICAL COHERENCE TOMOGRAPHY; MICRO-ANGIOGRAPHY; NEUROLOGICAL DISEASE; RETINAL BLOOD FLOW;

ANIMALS; BLOOD; COHERENT LIGHT; INTERFEROMETRY; LABELS; MICROCIRCULATION; OPHTHALMOLOGY; THREE DIMENSIONAL; TISSUE; TOMOGRAPHY;

BLOOD VESSELS;

EID: 77953291993     PISSN: 1077260X     EISSN: None     Source Type: Journal    
DOI: 10.1109/JSTQE.2009.2033609     Document Type: Article

References (34)

1. E. Yamada, M. Matsumura, S. Kyo, and R. Omoto, "Usefulness of a prototype intravascular ultrasound imaging in evaluation of aortic dissection and comparison with angiographic study, transesophageal echocardiography, computed tomography and magnetic resonance imaging," Am. J. Cardiol., vol.75, pp. 161-171, 1995.
2. T. Misgeld and M. Kerschensteiner, "In vivo imaging of the diseased nervous system," Nat. Rev. Neurosci., vol.7, pp. 449-463, 2006.
3. C. A. Molina and J. L. Saver, "Extending reperfusion therapy for acute ischemic stroke: Emerging pharmacological, mechanical, and imaging strategies," Stroke, vol.36, pp. 2311-2320, 2005.
4. G. W. Albers, P. Amarenco, J. D. Easton, R. L. Sacco, and P. Teal, "Antithrombotic and thrombolytic therapy for ischemic stroke," in Proc. 17th ACCP Conf. Antithrombotic Thrombolytic Therapy. Chest, 2004, vol.126S, pp. 483-512.
5. M. Fisher, J. A. Fernandez, S. F. Ameriso, D. Xie, A. Gruber, A. Paganini- Hill, and J. H. Griffin, "Activated protein C resistance in ischemic stroke not due to factor V arginine506→glutamine mutation," Stroke, vol.27, pp. 1163-1166, 1996.
6. D. Malonek, U. Dirnagl, U. Lindauer, K. Yamada, I. Kanno, and A. Grinvald, "Vascular imprints of neuronal activity: Relationships between the dynamics of cortical blood flow, oxygenation, and volume changes following sensory stimulation," Proc. Natl. Acad. Sci. USA, vol.94, pp. 14826-14831, 1997.
7. K. Hossmann, "Viability thresholds and the penumbra of focal ischemia," Ann. Neurol., vol.36, pp. 557-565, 1994.
8. McDonald and Choyke, "Imaging of angiogenesis: From microscope to clinic," Nat. Med., vol.9, pp. 713-725, 2003.
9. T. P. Padera, B. R. Stoll, P. T. So, and R. K. Jain, "Conventional and high speed intravital multiphoton laser scanning microscopy of microvasculature, lymphatics, and leukocyte-endothelial interactions," Mol. Imag., vol.1, pp. 9-15, 2002.
10. R. K. Jain, "Delivery of molecular medicine to solid tumors: Lessons from in vivo imaging of gene expression and function," J. Control Release, vol.74, pp. 7-25, 2001.
11. R. K. Wang, S. Jacques, Z. Ma, S. Hurst, S. Hanson, and A. Gruber, "Three dimensional optical angiography," Opt. Exp., vol.15, pp. 4083- 4097, 2007.
12. R. K. Wang and S. Hurst, "Mapping of cerebrovascular blood perfusion in mice with skin and cranium intact by optical micro-angiography at 1300 nm wavelength," Opt. Exp., vol.15, pp. 11402-11412, 2007.
13. R. K. Wang, "Three dimensional optical angiography maps directional blood perfusion deep within microcirculation tissue beds in vivo," Phys. Med. Biol., vol.52, pp. N531-N537, 2007.
14. R. K. Wang, "Directional blood flow imaging in volumetric optical microangiography achieved by digital frequency modulation," Opt. Lett., vol.33, no.16, pp. 1878-1880, 2008.
15. L. An and R. K.Wang, "In vivo volumetric imaging of vascular perfusion within human retina and choroids with optical microangiography," Opt. Exp., vol.16, pp. 11438-11452, 2008.
16. R. K. Wang and L. An, "Doppler optical microangiography for volumetric imaging of vascular perfusion in vivo," Opt. Exp., vol.17, no.11, pp. 8926-8940, 2009.
17. A. F. Fercher, W. Drexler, C. K. Hitzenberger, and T. Lasser, "Optical coherence tomography - principles and applications," Rep. Prog. Phys., vol.66, pp. 239-303, 2003.
18. P. H. Tomlins and R. K. Wang, "Theory, development and applications of optical coherence tomography," J Phys. D: Appl. Phys., vol.38, pp. 2519- 2535, 2005.
19. Z. P. Chen, T. E. Milner, S. Srinivas, X. Wang, A. Malekafzali, M. J. C. van Gemert, and J. S. Nelson, "Noninvasive imaging of in vivo blood flowvelocity using optical Doppler tomography," Opt. Lett., vol.22, pp. 1119-1121, 1997.
20. S. Makita, Y. Hong, M. Y. T. Yatagai, and Y. Yasuno, "Optical coherence angiography," Opt. Exp., vol.14, pp. 7821-7840, 2006.
21. R. K.Wang, "In vivo full range complex Fourier domain optical coherence tomography," Appl. Phys. Lett., vol.90, no.5, pp. 054103-1-054103-3, Jan. 2007.
22. R. K.Wang, "Fourier domain optical coherence tomography achieves full range complex imaging in vivo by introducing a carrier frequency during scanning," Phys. Med. Biol., vol.52, pp. 5897-5907, 2007.
23. L. An and R. K.Wang, "Use of scanner to modulate spatial interferogram for in vivo full range Fourier domain optical coherence tomography," Opt. Lett., vol.32, pp. 3423-3425, 2007.
24. M. J. L. Eliason, K. Sampei, A. S. Mandir, P. D. Hurn, R. J. Traystman, J. Bao, A. Pieper, Z. Q. Wang, T. M. Dawson, S. H. Snyder, and V. L. Dawson, "Poly (ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia," Nat. Med., vol.3, pp. 1089- 1095, 1997.
25. M. Shibata, S. R. Kumar, A. Amar, J. A. Fernandez, F. Hofman, J. H. Griffin, and B. V. Zlokovic, "Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke," Circulation, vol.103, pp. 1799-1805, 2001.
26. E. Kilic, D. M. Hermann, and K. A. Hossmann, "Recombinant tissue plasminogen activator reduces infarct size after reversible thread occlusion of middle cerebral artery in mice," Neuroreport, vol.10, pp. 107-111, 1999.
27. M. Sawada, N. J. Alkayed, S. Goto, B. J. Crain, R. J. Traystman, A. Shaivitz, R. J. Nelson, and P. D. Hurn, "Estrogen receptor antagonist ICI182,780 exacerbates ischemic injury in female mouse," J. Cereb. Blood Flow Metab., vol.20, pp. 112-118, 2000.
28. T. F. Choudhri, B. L. Hoh, C. J. Prestigiacomo, J. Huang, L. J. Kim, A. M. Schmidt, W. Kisiel, E. S. Connolly Jr, and D. J. Pinsky, "Targeted inhibition of intrinsic coagulation limits cerebral injury in stroke without increasing intracerebral hemorrhage," J. Exp. Med., vol.190, pp. 91-99, 1999.
29. P. Tabrizi, L. Wang, N. Seeds, J. G. McComb, S. Yamada, J. H. Griffin, P. Carmeliet, M. H. Weiss, and B. V. Zlokovic, "Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: Studies in tPA-deficient mice and wild-type mice on a matched genetic background," Arterioscler. Thromb. Vasc. Biol., vol.19, pp. 2801-2806, 1999.
30. T. Misgeld and M. Kerschensteiner, "In vivo imaging of the diseased nervous system," Nat. Rev. Neurosci., vol.7, pp. 449-463, 2006.
31. A. K. Dunn, H. Bolay, M. A. Moskowitz, and D. A. Boas, "Dynamic imaging of cerebral blood flow using laser speckle," J. Cereb. Blood Flow Metab., vol.21, pp. 195-201, 2001. (Pubitemid 32207418)
32. B. R. White, M. C. Pierce, N. Nassif et al., "In vivo dynamic human retinal blood flow imaging using ultrahigh-speed spectral domain optical Doppler tomography," Opt. Exp., vol.11, pp. 3490-3497, 2003.
33. S. Jiao, R. Knighton, X. Huang, G. Gregori, and C. A. Puliafito, "Simultaneous acquisition of sectional and fundus ophthalmic images with spectraldomain optical coherence tomography," Opt. Exp., vol.13, pp. 444-452, 2005.
34. J. R. Lindner, "Microbubbles in medical imaging: Current applications and future directions," Nat. Rev. Drug Discov., vol.3, pp. 527-532, 2004.